First Western Capital Management’s Biogen BIIB Stock Holding History

First Western Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-810	Closed	-$230K	–	80
2016 Q4	$230K	Sell	810 -484	-37%	-$143K	0.12%	90
2016 Q3	$405K	Buy	+1,294	New	+$383K	0.16%	95
2015 Q4	–	Sell	-5,575	Closed	-$1.63M	–	110
2015 Q3	$1.63M	Buy	5,575 +2,340	+72%	+$773K	0.54%	75
2015 Q2	$1.31M	Buy	3,235 +1,955	+153%	+$785K	0.42%	86
2015 Q1	$540K	Buy	+1,280	New	+$504K	0.16%	103
2014 Q1	–	Sell	-1,465	Closed	-$410K	–	131
2013 Q4	$410K	Buy	+1,465	New	+$379K	0.14%	121

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Western Capital Management's BIIB Position: Q1 2017 in Review

First Western Capital Management sold out of Biogen (BIIB) in Q1 2017, closing a stake of 810 shares — an estimated $230K sold.

First Western Capital Management first reported a position in BIIB in Q4 2013 and held it in 6 quarters. The position peaked at $1.63M in Q3 2015. 1,019 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

First Western Capital Management reported no remaining Biogen position as of Q1 2017 after selling out during the quarter.
First Western Capital Management sold 810 Biogen shares in Q1 2017, an estimated $230K.
First Western Capital Management first reported a position in Biogen in Q4 2013 and held it in 6 quarters.
First Western Capital Management's Biogen position peaked at $1.63M in Q3 2015.
1,019 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on First Western Capital Management's 13F filing for Q1 2017, filed 26 Apr 2017.